PALB2 Interest group PALB2 Gene Team Resources Publications Events Contact Us Blog 5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time 17th November 2025Read more5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London timeUK PALB2 Carriers Information Session (4th annual event) 16th October 2024 23rd March 2025Read moreUK PALB2 Carriers Information Session (4th annual event) 16th October 2024ASCO Post – Commentary on the PALB2 ACMG Management Guidelines 12th October 2021Read moreASCO Post – Commentary on the PALB2 ACMG Management GuidelinesBreast Cancer Survivor and Journalist Susan Berger talks about her experience of having a PALB2 mutation 28th September 2021Read moreBreast Cancer Survivor and Journalist Susan Berger talks about her experience of having a PALB2 mutationA story on PALB2 in the New York Times 18th August 2021Read moreA story on PALB2 in the New York TimesACMG PALB2 Clinical Guidelines now available 11th May 2021Read moreACMG PALB2 Clinical Guidelines now available >> more articles
5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time 17th November 2025Read more5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time
UK PALB2 Carriers Information Session (4th annual event) 16th October 2024 23rd March 2025Read moreUK PALB2 Carriers Information Session (4th annual event) 16th October 2024
ASCO Post – Commentary on the PALB2 ACMG Management Guidelines 12th October 2021Read moreASCO Post – Commentary on the PALB2 ACMG Management Guidelines
Breast Cancer Survivor and Journalist Susan Berger talks about her experience of having a PALB2 mutation 28th September 2021Read moreBreast Cancer Survivor and Journalist Susan Berger talks about her experience of having a PALB2 mutation
A story on PALB2 in the New York Times 18th August 2021Read moreA story on PALB2 in the New York Times
ACMG PALB2 Clinical Guidelines now available 11th May 2021Read moreACMG PALB2 Clinical Guidelines now available
